265 related articles for article (PubMed ID: 19819042)
1. [Efficacy and tolerability of cinitapride in the treatment of functional dyspepsia and delayed gastric emptying].
Portincasa P; Mearin F; Robert M; Plazas MJ; Mas M; Heras J
Gastroenterol Hepatol; 2009 Dec; 32(10):669-76. PubMed ID: 19819042
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of cinitapride in the treatment of mild to moderate postprandial distress syndrome-predominant functional dyspepsia.
Du Y; Su T; Song X; Gao J; Zou D; Zuo C; Xie W; Wang B; Zhang Z; Xu J; Tian D; Luo H; Zhang Z; Wang S; Chen J; Guo J; Gong L; Ding Y; Li Z
J Clin Gastroenterol; 2014 Apr; 48(4):328-35. PubMed ID: 24440931
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
[TBL] [Abstract][Full Text] [Related]
4. [Levosulpiride in the management of functional dyspepsia and delayed gastric emptying].
Serra J
Gastroenterol Hepatol; 2010 Oct; 33(8):586-90. PubMed ID: 20850200
[TBL] [Abstract][Full Text] [Related]
5. Randomized clinical trial: a controlled pilot trial of the 5-HT4 receptor agonist revexepride in patients with symptoms suggestive of gastroparesis.
Tack J; Rotondo A; Meulemans A; Thielemans L; Cools M
Neurogastroenterol Motil; 2016 Apr; 28(4):487-97. PubMed ID: 27010235
[TBL] [Abstract][Full Text] [Related]
6. The effect of metoclopramide on antral emptying of a semisolid meal in patients with functional dyspepsia. A randomized placebo controlled sonographic study.
Dumitraşcu DL; Ungureanu O; Verzea D; Pascu O
Rom J Intern Med; 1998; 36(1-2):97-104. PubMed ID: 10660974
[TBL] [Abstract][Full Text] [Related]
7. Clinical effects of STW 5 (Iberogast) are not based on acceleration of gastric emptying in patients with functional dyspepsia and gastroparesis.
Braden B; Caspary W; Börner N; Vinson B; Schneider AR
Neurogastroenterol Motil; 2009 Jun; 21(6):632-8, e25. PubMed ID: 19220753
[TBL] [Abstract][Full Text] [Related]
8. Influence of erythromycin on gastric emptying and meal related symptoms in functional dyspepsia with delayed gastric emptying.
Arts J; Caenepeel P; Verbeke K; Tack J
Gut; 2005 Apr; 54(4):455-60. PubMed ID: 15753526
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic efficacy of acotiamide in patients with functional dyspepsia based on enhanced postprandial gastric accommodation and emptying: randomized controlled study evaluation by real-time ultrasonography.
Kusunoki H; Haruma K; Manabe N; Imamura H; Kamada T; Shiotani A; Hata J; Sugioka H; Saito Y; Kato H; Tack J
Neurogastroenterol Motil; 2012 Jun; 24(6):540-5, e250-1. PubMed ID: 22385472
[TBL] [Abstract][Full Text] [Related]
10. [Possibilities of ultrasonography of gastric emptying].
Prassler R; Huchzermeyer H
Wien Med Wochenschr; 1996; 146(24):615-8. PubMed ID: 9123948
[TBL] [Abstract][Full Text] [Related]
11. Prokinetic effects of a new 5-HT
Yin J; Xu X; Song G; Han HS; Kim HW; Chen JD
J Gastroenterol Hepatol; 2017 Mar; 32(3):625-630. PubMed ID: 27418395
[TBL] [Abstract][Full Text] [Related]
12. A double-blind comparison of clebopride and placebo in dyspepsia secondary to delayed gastric emptying.
Bavestrello L; Caimi L; Barbera A
Clin Ther; 1985; 7(4):468-73. PubMed ID: 3893703
[TBL] [Abstract][Full Text] [Related]
13. Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study.
Murray CD; Martin NM; Patterson M; Taylor SA; Ghatei MA; Kamm MA; Johnston C; Bloom SR; Emmanuel AV
Gut; 2005 Dec; 54(12):1693-8. PubMed ID: 16085693
[TBL] [Abstract][Full Text] [Related]
14. Prucalopride in diabetic and connective tissue disease-related gastroparesis: Randomized placebo-controlled crossover pilot trial.
Andrews CN; Woo M; Buresi M; Curley M; Gupta M; Tack J; Wilsack L; Nasser Y
Neurogastroenterol Motil; 2021 Jan; 33(1):e13958. PubMed ID: 32743954
[TBL] [Abstract][Full Text] [Related]
15. [Gastric emptying in reflux esophagitis. Effect of metoclopramide and cinitapride].
Monés J; Espinós JC; Carrió I; Calabuig R; Vilardell F
Med Clin (Barc); 1989 Sep; 93(9):331-4. PubMed ID: 2691780
[TBL] [Abstract][Full Text] [Related]
16. Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial.
Talley NJ; Verlinden M; Geenen DJ; Hogan RB; Riff D; McCallum RW; Mack RJ
Gut; 2001 Sep; 49(3):395-401. PubMed ID: 11511562
[TBL] [Abstract][Full Text] [Related]
17. Dynamic antral scintigraphy to characterize gastric antral motility in functional dyspepsia.
Urbain JL; Vekemans MC; Parkman H; Van Cauteren J; Mayeur SM; Van den Maegdenbergh V; Charkes ND; Fisher RS; Malmud LS; De Roo M
J Nucl Med; 1995 Sep; 36(9):1579-86. PubMed ID: 7658213
[TBL] [Abstract][Full Text] [Related]
18. Nizatidine and gastric emptying in functional dyspepsia.
Koskenpato J; Punkkinen JM; Kairemo K; Färkkilä M
Dig Dis Sci; 2008 Feb; 53(2):352-7. PubMed ID: 17682943
[TBL] [Abstract][Full Text] [Related]
19. Efficacy of buspirone, a fundus-relaxing drug, in patients with functional dyspepsia.
Tack J; Janssen P; Masaoka T; Farré R; Van Oudenhove L
Clin Gastroenterol Hepatol; 2012 Nov; 10(11):1239-45. PubMed ID: 22813445
[TBL] [Abstract][Full Text] [Related]
20. A dose-ranging, placebo-controlled, pilot trial of Acotiamide in patients with functional dyspepsia.
Tack J; Masclee A; Heading R; Berstad A; Piessevaux H; Popiela T; Vandenberghe A; Kato H
Neurogastroenterol Motil; 2009 Mar; 21(3):272-80. PubMed ID: 19254354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
